Patent Number: 7,078,433

Title: FC101 and analogs as a method of treatment for cancer

Abstract: The present invention provides a treatment for angiogenic diseases, including solid tumors. The treatment consists of administering therapeutically active dosages of FC101, resulting in a reduction in endothelial cell proliferation and inhibition of new blood vessel formation. FC101 can also be used as a lead compound to develop other pharmacologically-active compounds, by adding or substituting different functional groups for those already present on the FC101 molecule.

Inventors: Wuthier; Roy E. (Columbia, SC), Nie; Daotai (Grosse Pointe Farms, MI)

Assignee: University of South Carolina

International Classification: A01N 43/16 (20060101); A61K 31/35 (20060101)

Expiration Date: 7/18/02018